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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S34736.78.7%, p<0.05). Also in OA, ES/BS was higher in severe lesions than
in moderate lesions (16.47.4% vs. 9.75.3% p<0.001), but not sig-
niﬁcantly higher in moderate than in normal-mild lesions (7.83.0% vs.
9.75.3%, p ¼ 0.17). The OS/BS was higher in moderate lesions than in
normal-mild lesions (18.011.5% vs. 10.54.1%, p<0.01), and was also
higher in severe than in moderate lesions (29.713.6% vs. 18.011.5%,
p<0.001).
Conclusions: In this cross-sectional study of human hip OA using
stereology-based quantitative histology on entire femoral heads, OA
was associated with increased bone mass and increased bone remod-
elling in the subchondral region. In the subchondral regionwith normal
or mildly affected cartilage and in the central region, bone remodelling
was higher in OA patients than in controls, although the bone mass did
not differ. Furthermore, subchondral bone volume and remodelling was
higher, the more severe the osteoarthritic lesions. Therefore, we con-
clude, that subchondral bone remodelling was affected already at an
early stage of OA, where changes in bone mass were not present.
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FIBRONECTIN FRAGMENT MEDIATES CARTILAGE CATABOLIC
PROCESS THROUGH TLR-2 SIGNALING PATHWAY IN HUMAN
ARTICULAR CHONDROCYTES
H. Kim, S. Park, E-J. Cheon, M. Lee, C. Yang, H. Hwang. Div of
rheumatology, Hallym Univ. Sacred Heart Hosp., Gyeonggi, Republic of
Korea
Purpose (the aim of the study): Fibronectin (FN), one of ECM protein
comprising cartilage, contributes to attachment, migration, and pro-
liferation of the cells. Also, increased level of ﬁbronectin fragments (FN-
fs), which are found in the synovial ﬂuid (SF) of osteoarthritis (OA)
patients, produces a potent catabolic effect in cartilage. However, little
is known about the cellular receptors and signaling mechanisms that
are mediated by FN-fs. Here we investigated whether the 29-kDa
amino-terminal FN-f (29-kDa FN-f) regulates cartilage metabolism via
Toll-like receptor-2 (TLR-2) signaling pathway in human articular
chondrocytes.
Methods: Human articular chondrocytes were enzymatically isolated
from articular cartilage obtained at the time of joint replacement sur-
gery of subjects with knee osteoarthritis, and cultured in monolayer. In
order to investigate whether 29-kDa FN-f induces MMPs production
through TLRs, human chondrocytes were transfected with TLR-2
expression plasmid or small interfering RNAs (siRNAs) targeting TLR-2
or TLR-4 andMyeloid differentiation factor 88 (MyD88). In 29-kDa FN-f-
stimulated chondrocytes, the relative levels of mRNA for matrix met-
alloproteinase 1 (MMP-1), MMP-3, and MMP-13 were analyzed by real-
time quantitative reverse transcription-polymerase chain reaction.
Protein expression levels of MMP-1 and MMP-3 and the regulatory
effect of TLR-2 on 29-kDa FN-f-mediated signaling pathways were
assessed by immunoblotting. MMP-13 production was measured by
ELISA. Association of 29-kDa FN-f with human chondrocytes through
TLR-2 was evaluated by ﬂuorescence microscopic analysis.
Results: Analysis of the expression of TLR family members in cartilage
tissues showed that TLR-2, 3, 4, and 5, except for TLR-1, were highly
expressed in OA cartilage compared to normal cartilage. Among FN and
various FN-fs including 29-, 45-, and 120-kDa FN-fs, in particular, 29-
kDa FN-f signiﬁcantly increased the expression of TLR-2 in human
chondrocytes in a dose- and time-dependent manner. To further con-
ﬁrm whether TLR-2 signaling pathway is involved in 29-kDa FN-f-
induced catabolic processes, the effect of 29-kDa FN-f on MMPs pro-
duction was investigated in TLR-2 knocked-down or overexpressed
chondrocytes. Our ﬁndings demonstrate that TLR-2 knockdown sig-
niﬁcantly inhibited 29-kDa FN-f-induced MMPs production at both
mRNA and protein levels but TLR-4 knockdown failed to do it. Con-
versely, TLR-2 overexpression led to enhanced production of MMPs by
29-kDa FN-f. In addition, knockdown of MyD88, a downstream adaptor
in TLR-2 signaling pathways, markedly reduced MMPs production
induced by 29-kDa FN-f. Also, knockdown of TLR-2 apparently inhibited
29-kDa FN-f-mediated activation of IkBa and p38, but not activation of
JNK and ERK. Exposure to SF from affected joints of OA patients highly
elevated the expression of MMP-1, -3, and -13 in primary chondrocytes
without reducing the cell viability. However, TLR-2 knockdown of
chondrocytes signiﬁcantly suppressed SF-induced MMP induction.
Conclusions: 29-kDa FN-f mediates catabolic responses in articular
chondrocytes through MyD88-dependent TLR-2 signaling pathway.Modulation of TLR-2-mediated signaling may be as a potential ther-
apeutic strategy for the prevention of cartilage degradation in OA.
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FSTL3: A NOVEL REGULATOR OF GROWTH PLATE DYNAMICS?
A. Burleigh y, K.A. Staines y, B. Poulet z, A.A. Pitsillides y, A. Mukherjee y.
y The Royal Vet. Coll., London, United Kingdom; zUniv. Coll. London,
London, United Kingdom
Purpose: The TGFb ligand superfamily have long been implicated in
development and maintenance of bone and cartilage. We have pre-
viously shown that mice deﬁcient in the activin/TGFb signalling
antagonist, Follistatin-like 3 (Fstl3-/-), develop spontaneous osteo-
arthritis with age, and exhibit premature growth plate closure. Herein,
we examine the hypothesis that Fstl3-/- mice have an altered endo-
chondral growth phenotype which reﬂects their predisposition to
developing osteoarthritis.
Methods: 4- and 8-week-old male Fstl3-/- and age-matched wild-type
mice were culled after treating for 1 week with 1mg/ml BrdU in
drinking water. Tibiae were analysed for standard cortical and tra-
becular parameters by microCT analysis. The endochondral growth
phenotype of these mice was assessed by standard histology of growth
plate structure; immunohistochemical labelling for Col10a1 and
Mmp13, (known markers of chondrocyte hypertrophy); Safranin O
staining and analysis of BrdU incorporation to examine cellular pro-
liferation (Invitrogen, CA, USA). Metatarsal rudiments were dissected
from E14.5 Fstl3-/- and wild-type (WT) embryos and cultured for up to
10 days. Mineralisation zone and metatarsal length was measured
digitally at several time points during culture.
Results: At 4-weeks Fstl3-/- mice displayed widened growth plates, cor-
responding to an increase in the size of the hypertrophic zone of chon-
drocytes, in comparison to age matchedWTmice. No striking differences
were seen in the growth plate measurements at 8 weeks. Fstl3-/- mice
showed decreased Safranin-O staining in the hypertrophic zone at both 4
and 8 weeks of age, indicating an alteration in the composition of sulph-
atedproteoglycans, anddisorderedcolumnarorganisationof growthplate
chondrocytes. Moreover, there was also an increased proportion and
intensity of BrdU positive labelling in 8, but not 4-week old, Fstl3-/- mice
when compared to WT mice. Immunolabelling for markers of chon-
drocyte hypertrophy at 4 wks of age revealed increases in MMP13
expression in Fstl3-/- growth plates, but a decreased expression of
Col10a1, which supports an alteration of the chondrocyte phentoype.
MicroCTanalysis revealed increased trabecular bone volume/total volume
(BV/TV), number and pattern factor in 4-week-old FSTL3 null mice com-
pared to WT mice. At 8-weeks of age, Fstl3-/- mice have increased tibia
length and microCT analysis reveals their increased trabecular thickness.
In E14.5 embryonic metatarsal organ cultures deletion of FSTL3 resulted
in accelerated mineralisation and increased growth compared to WT
controls.
Conclusions: Taken together, our initial data suggest that Fstl3-/- mice
display an accelerated bone and endochondral growth phenotype. This
may either contribute indirectly to their development of osteoarthritis
or may point to a fundamental chondrocyte deﬁcit that underpins
osteoarthritic initiation. Further studies into the precise growth plate
phenotype of Fstl3-/- mice may elucidate the molecular mechanisms
responsible for initiating osteoarthritis in these mice.
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A NEW ANIMAL MODEL FOR DETERMINING THE EFFECTS OF
DIABETES ON OSTEOARTHRITIS
M. Duran, L. Shum, R. Clark, M. McNulty, K.B. King. Univ. of Colorado Sch.
of Med., Aurora, CO, USA
Purpose: The prevalence of both type 2 diabetes and that of osteo-
arthritis (OA) are high and are increasing rapidly worldwide. A recent
publication indicates that within the US Veteran population, rates of
total joint replacement (likely due to severe OA) are 1) higher among
those with diabetes and 2) occur at younger ages in those with diabetes.
These two points together suggest that diabetes may have the effect of
either worsening or accelerating the progression of OA. However, due to
frequent co-morbid conditions associated with diabetes, testing the
effect of diabetes is challenging in human subjects. Although there are
several rodent models for type 2 diabetes, most require induction using
a high fat diet, a confounding factor expected to also affect OA. The
